J. Cosnes, G. Rousseau, C. Seksik, P. Cortot, and A. , Epidemiology and Natural History of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1785-1794, 2011.
DOI : 10.1053/j.gastro.2011.01.055

URL : https://hal.archives-ouvertes.fr/hal-00631553

S. Wilks, Morbid appearances in the intestines of Miss Bankes Lond Med Gaz, pp.264-265, 1859.

A. Dignass, R. Eliakim, F. Magro, C. Maaser, Y. Chowers et al., Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis, Journal of Crohn's and Colitis, vol.8, issue.76, pp.965-90, 2012.
DOI : 10.1097/00054725-200201000-00003

M. Silverberg, J. Satsangi, T. Ahmad, I. Arnott, C. Bernstein et al., Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working, 2005.

A. Kornbluth and D. Sachar, Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee, The American Journal of Gastroenterology, vol.4, issue.3, pp.501-524, 2010.
DOI : 10.1016/0016-5085(92)90831-I

B. Crohn, L. Ginzburg, and G. Oppenheimer, REGIONAL ILEITIS, Journal of the American Medical Association, vol.99, issue.16, pp.1323-1332, 1932.
DOI : 10.1001/jama.1932.02740680019005

C. Dejaco, C. Oesterreicher, S. Angelberger, A. Püspök, P. Birner et al., Diagnosing Colitis: a Prospective Study on Essential Parameters for Reaching a Diagnosis, Endoscopy, vol.35, issue.12, pp.1004-1012, 2003.
DOI : 10.1055/s-2003-44593

J. Satsangi, M. Silverberg, S. Vermeire, and J. Colombel, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-53, 2006.
DOI : 10.1136/gut.2005.082909

N. Molodecky, I. Soon, D. Rabi, W. Ghali, M. Ferris et al., Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review, Gastroenterology, vol.142, issue.1, pp.46-54, 2012.
DOI : 10.1053/j.gastro.2011.10.001

M. D. Kappelman, S. L. Rifas-shiman, and K. Kleinman, The Prevalence and Geographic Distribution of Crohn???s Disease and Ulcerative Colitis in the United States, Clinical Gastroenterology and Hepatology, vol.5, issue.12, pp.1424-1429, 2007.
DOI : 10.1016/j.cgh.2007.07.012

S. Shivananda, . Lennard-jones, and R. Logan, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)., Gut, vol.39, issue.5, pp.39-690, 1996.
DOI : 10.1136/gut.39.5.690

V. Nerich, E. Monnet, and A. Etienne, Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data, Inflammatory Bowel Diseases, vol.12, issue.3, pp.218-226, 2006.
DOI : 10.1053/gast.2003.50021

URL : https://hal.archives-ouvertes.fr/hal-00466309

F. Molinie, C. Gower-rousseau, and T. Yzet, Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France, Gut, pp.53-843, 1988.

L. Jostins, S. Ripke, R. Weersma, R. Duerr, D. Mcgovern et al., Host???microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, vol.286, issue.7422, pp.119-143, 2012.
DOI : 10.1074/jbc.M111.291492

H. Clevers, Inflammatory Bowel Disease, Stress, and the Endoplasmic Reticulum, New England Journal of Medicine, vol.360, issue.7, pp.726-733, 2009.
DOI : 10.1056/NEJMcibr0809591

E. Glocker, D. Kotlarz, K. Boztug, E. Gertz, A. Schäffer et al., Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor, New England Journal of Medicine, vol.361, issue.21, pp.2033-2078, 2009.
DOI : 10.1056/NEJMoa0907206

P. Barnes and K. M. , Nuclear factor-¬ B ? a pivotal transciption factor in chronic inflammatory diseases, N Engl J Med, vol.15, pp.1066-1071, 1997.

L. Chen, L. Egan, Z. Li, F. Greten, M. Kagnoff et al., The two faces of IKK and NF-??B inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion, Nature Medicine, vol.293, issue.5, pp.575-581, 2003.
DOI : 10.1126/science.1062677

I. Fuss, Is the Th1/Th2 paradigm of immune regulation applicable to IBD? Inflamm Bowel Dis, Inflamm Bowel Dis, vol.14, issue.2, 2008.

C. Dong, TH17 cells in development: an updated view of their molecular identity and genetic programming, Nature Reviews Immunology, vol.178, issue.5, pp.337-385, 2008.
DOI : 10.4049/jimmunol.178.6.3822

R. Duchmann, I. Kaiser, and E. Hermann, Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD), Clinical & Experimental Immunology, vol.19, issue.3, pp.448-55, 1995.
DOI : 10.1016/0016-5085(93)90169-D

T. Reichstein and V. Euw, ??ber Bestandteile der Nebennieren-Rinde VI. Trennungsmethoden, sowie Isolierung der Substanzen F. a. H und J, Helvetica Chimica Acta, vol.111, issue.1, pp.1107-1126, 1936.
DOI : 10.1002/hlca.19360190135

E. C. Kendall, M. H. Mckenzie, B. Myers, C. Koelsche, and G. , Isolation in crystalline form of the hormone essential to life from the suprarenal cortex; its chemical nature and physiologic properties, Mayo Clin Proc, vol.9, pp.245-250, 1934.

E. C. Kendall, H. Mason, and A. S. Myersc, A physiologic and chemical investigation of the suprarenal cortex, J Biol Chem, vol.114, pp.57-58, 1936.

G. Hunder and E. Matteson, L Rheumatology practice at Mayo Clinic: the first 40 years?, 1920.

G. W. Pickering, SIGNIFICANCE OF THE DISCOVERY OF THE EFFECTS OF CORTISONE ON RHEUMATOID ARTHRITIS, The Lancet, vol.256, issue.6620, pp.81-84, 1950.
DOI : 10.1016/S0140-6736(50)91038-5

R. G. Sprague, Cortisone and ACTH, The American Journal of Medicine, vol.10, issue.5, pp.567-594, 1951.
DOI : 10.1016/0002-9343(51)90329-4

S. Rivest, How circulating cytokines trigger the neural circuits that control the hypothalamic???pituitary???adrenal axis, Psychoneuroendocrinology, vol.26, issue.8, pp.761-88, 2001.
DOI : 10.1016/S0306-4530(01)00064-6

S. Truelove and L. Witts, Cortisone in Ulcerative Colitis, BMJ, vol.2, issue.4947, pp.1041-1049, 1955.
DOI : 10.1136/bmj.2.4947.1041

R. B. Woodward, F. Sondheimer, D. Taub, K. Heusler, and W. M. Mclamore, The total synthesis of steroids, J Am Chem Soc, pp.74-4223, 1952.

F. Chast, Histoire de la corticoth??rapie, La Revue de M??decine Interne, vol.34, issue.5, pp.258-63, 2013.
DOI : 10.1016/j.revmed.2012.12.009

S. Yang and L. Zhang, Glucocorticoids and Vascular Reactivity, Current Vascular Pharmacology, vol.2, issue.1, pp.1-12, 2004.
DOI : 10.2174/1570161043476483

V. Laudet, C. Hanni, J. Coll, F. Catzeflis, and D. Stehelin, Evolution of the nuclear receptor gene superfamily, EMBO J, vol.11, pp.1003-1016, 1992.

N. Lu and J. Cidlowski, The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms, Annals of the New York Academy of Sciences, vol.276, issue.1
DOI : 10.1091/mbc.11.3.799

T. Rhen and J. Cidlowski, Antiinflammatory Action of Glucocorticoids ??? New Mechanisms for Old Drugs, New England Journal of Medicine, vol.353, issue.16
DOI : 10.1056/NEJMra050541

T. Tanabe and N. Tohnai, Cyclooxygenase isozymes and their gene structures and expression, Prostaglandins & Other Lipid Mediators, vol.68, issue.69, pp.68-6995, 2002.
DOI : 10.1016/S0090-6980(02)00024-2

O. Kassel, A. Sancono, J. Krätzschmar, B. Kreft, M. Stassen et al., Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1, The EMBO Journal, vol.20, issue.24, pp.7108-7124, 2001.
DOI : 10.1093/emboj/20.24.7108

H. Schäcke, W. Döcke, and K. Asadullah, Mechanisms involved in the side effects of glucocorticoids, Pharmacology & Therapeutics, vol.96, issue.1
DOI : 10.1016/S0163-7258(02)00297-8

N. Williet, C. Pillot, A. Oussalah, V. Billioud, J. Chevaux et al., Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflammatory Bowel Diseases, vol.132, issue.9, pp.1641-1647, 2012.
DOI : 10.1053/j.gastro.2006.11.015

L. Peyrin-biroulet, A. Oussalah, N. Williet, C. Pillot, L. Bresler et al., Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011.
DOI : 10.1136/gut.2010.227884

L. Targownik, Z. Nugent, H. Singh, and C. Bernstein, Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.54, issue.4, pp.622-652
DOI : 10.1136/gut.2004.045294

W. Faubion, . Jr, E. Loftus, . Jr, W. Harmsen et al., The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study, Gastroenterology, vol.121, issue.2, pp.255-60, 2001.
DOI : 10.1053/gast.2001.26279

A. Dignass, J. Lindsay, A. Sturm, A. Windsor, J. Colombel et al., Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management, Journal of Crohn's and Colitis, vol.80, issue.Suppl. III, pp.991-1030, 2012.
DOI : 10.1159/000212075

P. Rutgeerts, R. Löfberg, H. Malchow, C. Lamers, G. Olaison et al., A Comparison of Budesonide with Prednisolone for Active Crohn's Disease, New England Journal of Medicine, vol.331, issue.13, pp.842-847, 1994.
DOI : 10.1056/NEJM199409293311304

W. Almawi, H. Beyhum, A. Rahme, and M. Rieder, Regulation of cytokine and cytokine receptor expression by glucocorticoids, Journal of Leukocyte Biology, vol.60, issue.5, pp.563-72, 1996.
DOI : 10.1002/jlb.60.5.563

F. Aberra, J. Lewis, D. Hass, J. Rombeau, B. Osborne et al., Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients, Gastroenterology, vol.125, issue.2, pp.320-327, 2003.
DOI : 10.1016/S0016-5085(03)00883-7

J. Rahier, T. Moreels, D. Munter, P. , D. Haens et al., Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium, Acta Gastro- Enterol Belg. mars, vol.73, issue.1, pp.41-46, 2010.

J. Rahier, F. Magro, C. Abreu, A. Armuzzi, S. Ben-horin et al., Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease, Journal of Crohn's and Colitis, vol.8, issue.6, pp.443-68, 2014.
DOI : 10.1016/j.crohns.2013.12.013

A. Dignass, G. Van-assche, J. Lindsay, M. Lémann, J. Söderholm et al., The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management, Journal of Crohn's and Colitis, vol.136, issue.S1, pp.28-62, 2010.
DOI : 10.1007/s00384-008-0542-9

W. Sandborn, B. Feagan, P. Rutgeerts, S. Hanauer, J. Colombel et al., Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease, New England Journal of Medicine, vol.369, issue.8, 2013.
DOI : 10.1056/NEJMoa1215739

A. Coulomb, Baumelou A, « Situation de l'automédication en France et perspectives d'évolution

T. Nelson and ?. Sofres, Information et automédication, 2001.

M. Ruiz, Risks of Self-Medication Practices, Current Drug Safety, vol.5, issue.4, pp.315-338, 2010.
DOI : 10.2174/157488610792245966

P. Munkholm, E. Langholz, M. Davidsen, and V. Binder, Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut, pp.360-362, 1994.

A. Robinson, D. Thompson, D. Wilkin, C. Roberts, N. Gastrointestinal-research et al., Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial, The Lancet, vol.358, issue.9286, pp.976-81, 2001.
DOI : 10.1016/S0140-6736(01)06105-0

E. Padoveze, L. Nascimento, F. Ferreira, and V. Neves, Cross-sectional descriptive study of topical self-medication in a hospital dermatology department in the state of S??o Paulo, Anais Brasileiros de Dermatologia, vol.32, issue.1, pp.163-168, 2012.
DOI : 10.1590/S0034-89101998000100006

M. Corrêa-fissmer, M. Mendonça, A. Martins, and D. Galato, Prevalence of self-medication for skin diseases: a systematic review, Anais Brasileiros de Dermatologia, vol.44, issue.4, pp.625-655, 2014.
DOI : 10.1590/S0034-89102010000400002

E. Estève, C. Ah-toye, A. Nseir, and L. Martin, Autom??dication et dermatoses aigu??s : ??tude prospective de 111 malades hospitalis??s, Annales de Dermatologie et de V??n??r??ologie, vol.132, issue.4, pp.372-375, 2005.
DOI : 10.1016/S0151-9638(05)79287-5

T. Serradori, A. Germain, M. Scherrer, C. Ayav, M. Perez et al., The effect of immune therapy on surgical site infection following Crohn's Disease resection, British Journal of Surgery, vol.19, issue.Suppl, pp.1089-93
DOI : 10.1111/j.1365-2036.2004.01904.x

B. Bielory and L. Bielory, Over-the-counter migration of steroid use, Current Opinion in Allergy and Clinical Immunology, vol.14, issue.5, pp.471-477, 2014.
DOI : 10.1097/ACI.0000000000000099

J. Cohen, A. Millier, S. Karray, and M. Toumi, Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development, Journal of Medical Economics, vol.16, issue.6, pp.835-879, 2013.
DOI : 10.3111/13696998.2013.793693

M. Elkjaer, M. Shuhaibar, J. Burisch, Y. Bailey, H. Scherfig et al., E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ???Constant-care??? approach, Gut, vol.59, issue.12, pp.1652-61, 2010.
DOI : 10.1136/gut.2010.220160

/. Mg and . Day, The doses of the induction treatment are shown in Table

L. Targownik, Z. Nugent, H. Singh, and C. Bernstein, Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.54, issue.4, pp.622-652, 2014.
DOI : 10.1136/gut.2004.045294

A. Dignass, J. Lindsay, A. Sturm, A. Windsor, J. Colombel et al., Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management, Journal of Crohn's and Colitis, vol.80, issue.Suppl. III, pp.991-1030, 2012.
DOI : 10.1159/000212075

S. Danese, D. Hoore, A. Gassull, M. Gomollón, F. Hommes et al., European Crohn's and Colitis Organisation (ECCO) The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management, J Crohns Colitis, vol.4, pp.28-62, 2010.

L. Biroulet, Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflamm Bowel Dis, vol.18, pp.1641-1647, 2012.

L. Peyrin-biroulet, A. Oussalah, N. Williet, C. Pillot, L. Bresler et al., Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011.
DOI : 10.1136/gut.2010.227884

M. Ruiz, Risks of Self-Medication Practices, Current Drug Safety, vol.5, issue.4, pp.315-338, 2010.
DOI : 10.2174/157488610792245966

P. Rutgeerts, R. Löfberg, H. Malchow, C. Lamers, G. Olaison et al., A Comparison of Budesonide with Prednisolone for Active Crohn's Disease, New England Journal of Medicine, vol.331, issue.13, pp.842-847, 1994.
DOI : 10.1056/NEJM199409293311304

H. Schäcke, W. Döcke, and K. Asadullah, Mechanisms involved in the side effects of glucocorticoids, Pharmacology & Therapeutics, vol.96, issue.1
DOI : 10.1016/S0163-7258(02)00297-8

P. Munkholm, E. Langholz, M. Davidsen, and V. Binder, Frequency of glucocorticoid resistance and dependency in Crohn's disease., Gut, vol.35, issue.3, pp.360-362, 1994.
DOI : 10.1136/gut.35.3.360

W. Faubion, . Jr, E. Loftus, . Jr, W. Harmsen et al., The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study, Gastroenterology, vol.121, issue.2, pp.255-60, 2001.
DOI : 10.1053/gast.2001.26279

A. Dignass, R. Eliakim, F. Magro, C. Maaser, Y. Chowers et al., Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis, Journal of Crohn's and Colitis, vol.8, issue.76, pp.965-90, 2012.
DOI : 10.1097/00054725-200201000-00003

A. Robinson, D. Thompson, D. Wilkin, and C. Roberts, Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial, The Lancet, vol.358, issue.9286, pp.976-81, 2001.
DOI : 10.1016/S0140-6736(01)06105-0

E. Padoveze, L. Nascimento, F. Ferreira, and V. Neves, Cross-sectional descriptive study of topical self-medication in a hospital dermatology department in the state of S??o Paulo, Anais Brasileiros de Dermatologia, vol.32, issue.1, pp.163-168, 2012.
DOI : 10.1590/S0034-89101998000100006

M. Corrêa-fissmer, M. Mendonça, A. Martins, and D. Galato, Prevalence of self-medication for skin diseases: a systematic review, Anais Brasileiros de Dermatologia, vol.44, issue.4, pp.625-655, 2014.
DOI : 10.1590/S0034-89102010000400002

E. Estève, C. Ah-toye, A. Nseir, and L. Martin, Autom??dication et dermatoses aigu??s : ??tude prospective de 111 malades hospitalis??s, Annales de Dermatologie et de V??n??r??ologie, vol.132, issue.4, pp.372-375, 2005.
DOI : 10.1016/S0151-9638(05)79287-5

T. Serradori, A. Germain, M. Scherrer, C. Ayav, M. Perez et al., The effect of immune therapy on surgical site infection following Crohn's Disease resection, British Journal of Surgery, vol.19, issue.Suppl, pp.1089-93, 2013.
DOI : 10.1111/j.1365-2036.2004.01904.x

B. Bielory and L. Bielory, Over-the-counter migration of steroid use, Current Opinion in Allergy and Clinical Immunology, vol.14, issue.5, pp.471-477, 2014.
DOI : 10.1097/ACI.0000000000000099

J. Cohen, A. Millier, S. Karray, and M. Toumi, Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development, Journal of Medical Economics, vol.16, issue.6, pp.835-879, 2013.
DOI : 10.3111/13696998.2013.793693

M. Elkjaer, M. Shuhaibar, J. Burisch, Y. Bailey, H. Scherfig et al., E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ???Constant-care??? approach, Gut, vol.59, issue.12, pp.1652-61, 2010.
DOI : 10.1136/gut.2010.220160